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In Vivo 1H NMR Spectroscopy of the Human Brain at 7 T
Ivan Tka´cˇ,* Peter Andersen, Gregor Adriany, Hellmut Merkle, Kaˆmil Ugˇurbil,
and Rolf Gruetter
In vivo 1H NMR spectra from the human brain were measured at
7 T. Ultrashort echo-time STEAM was used to minimize J-
modulation and signal attenuation caused by the shorter T2 of
metabolites. Precise adjustment of higher-order shims, which
was achieved with FASTMAP, was crucial to benefit from this
high magnetic field. Sensitivity improvements were evident
from single-shot spectra and from the direct detection of glu-
cose at 5.23 ppm in 8-ml volumes. The linewidth of the creatine
methyl resonance was at best 9 Hz. In spite of the increased
linewidth of singlet resonances at 7 T, the ability to resolve
overlapping multiplets of J-coupled spin systems, such as glu-
tamine and glutamate, was substantially increased. Character-
istic spectral patterns of metabolites, e.g., myo-inositol and
taurine, were discernible in the in vivo spectra, which facilitated
an unambiguous signal assignment. Magn Reson Med 46:
451–456, 2001. © 2001 Wiley-Liss, Inc.
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NMR spectrometers, operating at ultrahigh magnetic fields
of 14–21 T, are routinely used for structural studies of
complex molecules such as proteins or nucleic acids (1).
However, the development of in vivo high-field NMR spec-
troscopy was delayed due to hardware limitations, such as
the availability of wide-bore magnets, increased demands
on gradient performance, and a lack of efficient methods to
correct the B0 field inhomogeneity induced by the subject
(shimming). Today, most of the clinical MR scanners
equipped with spectroscopy packages operate at 1.5 T. In
addition to N-acetylaspartate (NAA), creatine (Cr), choline
(Cho), and lactate (Lac), quantification of other metabolites
such as myo-inositol (Ins) and glutamate/glutamine was
reported in short echo-time spectra (2,3). Increased accu-
racy and reliability of quantification was achieved at 2 T
(4), which allowed the assessment of regional changes of
brain metabolites, including N-acetylaspartylglutamate
(NAAG) (5).
Preliminary results obtained in the late 1980s demon-
strated the feasibility of in vivo 1H NMR spectroscopy of
human brain at 4 T and confirmed the expected increased
sensitivity (6,7). Nonlinear field deformations induced by
susceptibility differences between air and tissue at 4 T
were not correctable by linear shims alone. Gruetter et al.
have shown that adjustment of all first- and second-order
shims by FASTMAP (fast, automatic shimming technique
by mapping along projections) (8) resulted in significantly
improved spectral resolution at 4 T relative to 1.5 T, yield-
ing partially resolved glutamine and glutamate signals (9).
Increased spectral dispersion at 4 T enabled the direct
detection of a glucose signal at 5.23 ppm for the first time,
even at very low concentration (10). Recent comparisons
of short echo-time 1H NMR spectroscopy at 1.5 T and 4 T
confirmed that a nearly fourfold increase in quantification
precision can be achieved at the higher field for J-coupled
metabolites such as glutamate (Glu), glutamine (Gln), and
g-aminobutyric acid (GABA) (11). T1 relaxation times of
metabolites (NAA, Cr, Cho) at 4 T (12) were found to be
only slightly larger than those reported at 1.5 T. However,
apparent T2-values were significantly shorter (12,13) than
at 1.5 T. Increased sensitivity at 4 T has allowed increased
spatial resolution in spectroscopic imaging (SI), which
resulted in the evaluation of metabolite concentration dif-
ferences between gray and white matter based on image
segmentation (14,15). Increased signal separation at 4 T
minimized the contamination of glutamate and GABA sig-
nals by unwanted resonances when measured by homo-
nuclear editing techniques (16,17).
Magnetic fields higher than 4 T have been employed in
1H spectroscopy studies of animal brains. In vivo 1H NMR
spectroscopy at 7 T was used to quantify metabolite con-
centrations in the brain of gerbils (18) and to monitor the
changes during and after acute hypoxia-ischemia in new-
born piglets (19). Spatial distribution of a limited number
of metabolites was assessed in rat brain using 2D and 3D SI
(20,21). The 2D-spatial/2D-spectral SI technique was used
to improve the resolution of spectra measured from intra-
cerebral gliomas in rat brain (22). However, limited spec-
tral resolution resulting from uncompensated B0 gradients
was a common feature of all aforementioned experiments
performed on animals at 7 T. Gruetter et al. (9) demon-
strated that spectra with excellent resolution can be mea-
sured also in vivo at 9.4 T, when all first- and second-order
shim terms were correctly set by FASTMAP (8,9). Subse-
quently, Pfeuffer et al. (23) showed that quantification of
18 metabolites in rat brain at 9.4 T was possible when
FASTMAP shimming (8,9), highly efficient water suppres-
sion (24), ultrashort echo-time STEAM (TE 5 1 ms) (24),
and LCModel data processing (25) were combined. In ad-
dition to commonly measured metabolites such as total
creatine, NAA, Cho, Glu, Gln, Lac, and Ins, concentrations
of alanine (Ala), aspartate (Asp), glutathione (GSH),
GABA, phosphorylethanolamine (PE), and taurine (Tau)
were quantified. The resolved signals of methylene groups
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of Cr and PCr were clearly discernible in 1H NMR spectra
of rat brain.
The purpose of this article is to report preliminary re-
sults concerning the sensitivity and resolution of 1H MRS
in the human brain using a whole-body 7 T magnet.
METHODS
A total of 18 subjects were studied after giving informed
consent according to procedures approved by the Institu-
tional Review Board and the FDA. The measurements
were performed on a 7 T / 90 cm magnet (Magnex Scien-
tific, Abingdon, UK) with a head gradient coil (40 mT/m,
500 ms) and a Turbo/Ultra gradient power amplifier (Sie-
mens AG, Medical Engineering, Erlangen, Germany) inter-
faced to a Varian INOVA console (Varian, Palo Alto, CA).
A shielded quadrature transmit/receive surface RF coil
(26) consisting of two geometrically decoupled single-turn
coils with 12-cm diameter each was used to measure spec-
tra from the occipital lobe. To measure spectra from the
parietal white matter, a circularly polarized helmet RF coil
(27) was used. All first- and second-order shim terms were
adjusted based on a recently improved FASTMAP se-
quence using EPI readout (28). The water signal was sup-
pressed by eight variable power RF pulses with optimized
relaxation delays (VAPOR) (24). Transmitter power of the
fifth water suppression RF pulse was increased by 4 dB,
the powers of the third, seventh, and eighth pulse were
increased by 5 dB relative to the nominal RF power used
for water suppression. The following interpulse delays
were used in VAPOR: 150 ms – 100 ms – 122 ms – 105 ms
– 102 ms – 61 ms – 67 ms – 14 ms. Three outer volume
suppression (OVS) blocks, each consisting of six hyperbol-
ic-secant RF pulses (8 kHz bandwidth) were interleaved
with water suppression pulses. An ultrashort echo-time
STEAM localization sequence with asymmetric RF pulses
(24) was adapted to the 7-T system. The displacement
error was reduced by using the highest RF power (2.3 kW)
currently available at the RF coil port. The resulting peak
amplitude of RF field (B1) in the selected volume of inter-
est (VOI) of the brain (gB1/2p 5 1.1–1.5 kHz, where g is the
gyromagnetic ratio) limited the shortest achievable dura-
tion of the asymmetric RF pulses to 1.5 ms (4.5 kHz band-
width) and shortest echo time to 6 ms. The position of the
VOI in the occipital lobe was chosen based on FLASH
images. Power absorption (SAR) was well within FDA
guidelines.
RESULTS
Automatically adjusted shim currents never reached max-
imum settings due to the strong shim coils specifically
designed for this 7 T magnet. Shimming resulted in water
linewidths of 11–13 Hz with a concomitant creatine line-
width of 9–11 Hz. To minimize the effect of drifting B0 or
subject movement on signal line width, data were always
acquired as a series of FIDs (consisting of 16 averages each)
that were saved in memory separately. The FIDs were
individually corrected for frequency drift and then
summed together and processed (weighted FT and zero-
order phase correction). Further improvements were not
noticeable when data were acquired as an array of single-
shot FIDs and when each FID was corrected for frequency
drift before summation. Approximately a twofold increase
in RF power was necessary at 7 T relative to 4 T to achieve
the same peak B1 in the same location of the brain, using
RF coils of the same design and similar loop size. The
short echo-time (TE 5 6 ms) minimized signal attenuation
due to T2 relaxation and J-modulation effects. The single-
shot 1H NMR spectrum measured from an 8-ml volume
located in occipital lobe (Fig. 1, top trace) demonstrated
increased sensitivity at 7 T. Approximately a twofold in-
crease in SNR was observed at 7 T relative to spectra
acquired at 4 T. In an averaged spectrum, the H-1 a-glu-
cose signal at 5.23 ppm was detectable (Fig. 1, bottom
trace) in healthy subjects without exogenous glucose ad-
ministration. In spite of an ultrashort TE of 6 ms, very
broad signals and baseline distortions were not observed.
The expanded region of a 1H NMR spectrum measured
from occipital gray matter (Fig. 2) demonstrates improve-
ments in spectral resolution achievable at 7 T. The gluta-
mate and glutamine resonances at 2.35 and 2.45 ppm were
clearly separated. In addition to the strong signals from
NAA, Ins, Glu, and total Cr, signal contributions from
aspartate (2.8 ppm), GABA (2.28 ppm), PE (3.98 ppm), and
scyllo-inositol (scyllo-Ins, 3.34 ppm) (29) were discernible
in the 7 T spectra. The upfield shoulder at the position of
the Cr methyl signal can be assigned to glutathione and
underlying macromolecule resonances. An expanded part
of the in vivo spectrum was compared to the spectra of
Tau, glucose, and Ins measured in phantoms (Fig. 2, top).
All resonances of Ins in the in vivo spectrum were in
FIG. 1. In vivo 1H NMR spectra of human brain (occipital gray
matter) measured at 7 T by the STEAM sequence with VAPOR water
suppression (24) using a quadrature transmit/receive surface RF coil
(26). Single shot spectrum, number of transients NT 5 1 (top trace),
averaged spectrum, NT 5 160 (bottom trace). TE 5 6 ms, TM 5
32 ms, TR 5 5 s, VOI 5 8 ml. After Gaussian multiplication (gf 5 0.1)
of FID and FT only zero-order phase correction applied. Inset:
gradient echo MRI with the location of VOI, transverse slice.
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excellent agreement with the solution spectrum. The glu-
cose spectrum was scaled according to the H-1 signal of
a-Glc at 5.23 ppm (not shown). The peak at 3.42 ppm in
the spectrum from the brain corresponded to the chemical
shift of the SCH2 group of Tau and was clearly different
from the glucose signal at 3.45 ppm. The concentration of
Tau in occipital gray matter was estimated to be ;1.5
mmol/g. In addition, the line-shape of the creatine/phos-
phocreatine signal at 3.92 ppm was non-Lorentzian and
asymmetric and the linewidth was clearly different from
that of the methyl resonance at 3.03 ppm. A resolved
signal NAAG, observed in a parietal white matter spec-
trum (Fig. 3), was another demonstration of improved
signal separation at 7 T. The signal of resting Lac at
1.32 ppm was detectable in some spectra (Fig. 3).
In order to estimate the best linewidth achievable at 7 T
in adult human brain spectra, the Hahn transverse relax-
ation times, T2, of methyl protons of Cr and NAA were
measured along with the best achievable linewidth of the
creatine methyl resonance. A series of 1H NMR spectra
obtained at echo times ranging from 10–250 ms were mea-
sured from occipital gray matter of three subjects in order
to assess the T2 relaxation times of the methyl groups of
NAA and Cr (Fig. 4). Signals of NAA and Cr were quanti-
fied using spectrometer built-in peak fitting procedures,
while the frequencies and linewidths of the underlying
broad resonances were kept fixed. The signal integrals as a
function of TE were fitted with a single exponential func-
tion. The T2 of the methyl protons of NAA was 141 6
11 ms (mean 6 SE, n 5 3) and 87 6 5 ms for the methyl
protons of Cr plus PCr. The linewidth Dy1/2 can be decom-
posed into a contribution from T2 and microscopic and
macroscopic susceptibility (Dy* and Dymacro, respectively)
according to:
Dn1/2 5
1
p z T2
1 Dn* 1 Dnmacro.
FIG. 2. In vivo 1H NMR spectrum from occipital
lobe measured at 7 T. STEAM, TE 5 6 ms, TM 5
32 ms, TR 5 5 s, VOI 5 8 ml, NT 5 160, resolution
enhancement by shifted Gaussian function gf 5
0.15 and gfs 5 0.08 (bottom trace). Top: expanded
part of the in vivo spectrum (gf 5 0.10 and gfs 5
0.10) compared to line-broadened solution spectra
of taurine, glucose, and myo-inositol. Inset: trans-
verse gradient echo MRI with the location of VOI,
obtained with a quadrature transmit/receive sur-
face RF coil (26).
FIG. 3. In vivo 1H NMR spectrum from parietal white matter mea-
sured at 7 T. STEAM, TE 5 6 ms, TM 5 32 ms, TR 5 5 s, VOI 5 8 ml,
NT 5 160, resolution enhancement by shifted Gaussian function
(gf 5 0.15 and gfs 5 0.08). Inset: gradient echo transverse MRI with
the location of VOI, obtained with a circularly polarized helmet RF
coil (27).
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Based on the observation that the water Dy1/2 was inde-
pendent of voxel size (from 1–8 ml), we assumed that the
macroscopic susceptibility term (Dymacro) was eliminated
by FASTMAP shimming. The microscopic susceptibility
term, Dy*, which leads to magnetization dephasing and
additional line broadening, was calculated from the exper-
imentally determined Dy1/2 and T2. The linewidths of Cr at
4 and 7 T and the contributions from T2 and Dy
* are
summarized in Table 1. In conjunction with the Dy1/2 and
the T2 measurements at both fields, it was possible to
estimate whether the observed linewidth at 7 T was con-
sistent with the 7/4 increase expected for Dy* and the
experimentally measured modest decrease of T2 at 7 T.
The observed Dy* at 7 T was 1.8 times higher than at 4 T,
which was within 5% of the expected increase.
To demonstrate the improvement in resolution for dif-
ferent J-coupled spin-systems, spectra of glutamate and
glutamine at 1.5, 4, and 7 T were simulated (Fig. 5) using
published values of chemical shifts and J-couplings (30)
and standard Varian simulation software. The overall
widths of the multiplets are predominantly determined by
the coupling patterns and the magnitudes of homonuclear
spin–spin coupling constants, as long as the Dy1/2 of sin-
glet resonances are comparable to the J-couplings con-
stants. Therefore, in spite of the increased linewidths of
singlet resonances at 7 T, the spectral resolution for cou-
pled spin systems such as Gln and Glu was substantially
improved.
DISCUSSION
A short echo-time localization sequence, originally devel-
oped for localized proton NMR spectroscopy of animals at
9.4 T with a TE of 1 ms, was adapted to a whole-body 7-T
system. Despite the reduced RF field and gradient strength
relative to the animal system, an echo time of 6 ms was
achieved, which minimized T2 losses and J-coupling ef-
fects. The highest accessible peak B1 was the limiting
factor for the reduction of the chemical displacement er-
ror. The highest achievable bandwidth for the asymmetric
slice-selective RF pulses resulted in a 20% displacement
FIG. 4. In vivo 1H NMR spectra from occipital lobe measured at
different echo times TE 5 10–250 ms. STEAM, TM 5 32 ms, TR 5
5 s, VOI 5 8 ml, NT 5 8. Processing: Gaussian multiplication (gf 5
0.10), FT, and zero-order phase correction.
Table 1
Linewidths of Methyl Resonance of Total Creatine at 4 T and 7 T
and Their Decompositions Into Contributions From T2 and
Microscopic Susceptibility Variations
B0 (T) Dn1/2 (Hz) 1/(pT2) (Hz) Dn* (Hz)
4 5.5 2.3 3.2
7 9.5 3.7 5.8
Dn1/2 5 experimentally measured linewidth of Cr at 4 T and 7 T.
1/(pT2) 5 contribution of the Hahn T2 to the linewidth of total
creatine signal at 3.03 ppm, T2 at 7 T was experimentally measured
in this study, T2 at 4 T was set to 140 ms according to previous
reports (10,12,13).
Dn* 5 line-broadening due to microscopic susceptibility variation
calculated as (Dn1/2 2 1/pT2).
FIG. 5. Simulated 1H NMR spectra of glutamine and glutamate at
different magnetic field strengths. Linewidths (Dy1/2) corresponded
to values typical for very well shimmed volumes of the human brain.
The concentration ratio [Glu]/[Gln] was set to 3 (5,11). Chemical
shifts and J-coupling constants were taken from Ref. (30). Fre-
quency scale (Hz) is identical in all three spectra.
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of the voxel along each dimension for signals separated by
3 ppm.
The short echo-time of 6 ms was possible due to asym-
metric RF pulses, which were used for voxel selection as
in our previous study (24). The short echo-time required
fine adjustment of the preemphasis to minimize eddy cur-
rent effects on signal line-shapes. This was achieved using
quantitative mapping methods (31). Localization perfor-
mance of the sequence was improved by outer volume
suppression, which reduced potential imperfections of
slice selection pulses in STEAM and eliminated the con-
tamination of spectra with signals originating outside of
the VOI. Broadband (8 kHz) hyperbolic secant RF pulses
used in OVS guaranteed that the displacement of slabs
saturated by OVS was similar to the displacement of the
VOI selected by STEAM, i.e., off-resonance signals in the
VOI were not partially suppressed by OVS. Short echo-
time STEAM combined with OVS and highly efficient
VAPOR water suppression (24) resulted in a flat baseline
(Fig. 1) achieved without any further postacquisition cor-
rection, such as water signal removal and baseline correc-
tion. The high frequency-selectivity of the water suppres-
sion was demonstrated by the reliable detection of the
a-glucose signal (5.23 ppm) in close proximity to the water
resonance.
To take advantage of the increased chemical shift dis-
persion at 7 T, shimming was crucial. FASTMAP shim-
ming resulted in convergence of all first- and second-order
shim terms in 3–4 iterations. The linewidth independence
of the volume size (from 8 ml to 1 ml) implied that the
shimming was optimal. The best linewidths observed for
water signals were 12 Hz and 11 Hz in voxels located in
gray and white matter, respectively. Corresponding Cr
linewidths were approximately 2 Hz narrower. The calcu-
lated microscopic susceptibility terms, Dy*, for the Cr sig-
nals at 4 and 7 T (Table 1) were in agreement with the
predicted proportionality to B0. From this comparison we
estimate that a linewidth of ;9 Hz may be the resolution
limit for 1H NMR spectroscopy of adult human brain at
7 T. In anesthetized rat brain at 9.4 T, similar linewidths
were observed, even though larger values were expected.
The T2 values of metabolites appear to be in general longer
in rat brain than in human brain, e.g., Cr T2 of 180 ms in rat
brain at 4.7 T (32) vs. 140 ms in human brain at 4 T
(10,12,13). However, those differences in T2 cannot fully
explain the observed differences in the linewidth. The
anesthetized rat and the nonanesthetized human brain are
expected to be different with respect to microscopic sus-
ceptibility variations between tissue and deoxyhemoglo-
bin-containing blood vessels. For example, in the anesthe-
tized rat, oxygen extraction is reduced and hence oxygen-
ation of blood is increased (33). Differences with respect to
vascular architecture between the rat and human brain
may also contribute to different microscopic field inhomo-
geneity effects.
The single-shot spectrum obtained from an 8-ml volume
of the human brain (Fig. 1) illustrates improved sensitivity
at 7 T. Additional demonstration of increased sensitivity at
7 T was the direct detection of the glucose signal at
5.23 ppm from an 8-ml brain volume of normal subjects
without using glucose infusion. At 4 T, significantly larger
volumes were required using the same number of averages
(34).
In spite of a modestly increased linewidth at 7 T, im-
provements in spectral resolution were evident, due to the
increased separation between signals of coupled spins. For
several metabolites, such as Ins and Tau, characteristic
spectral patterns were discernible in the in vivo spectrum
(Fig. 2), which facilitated an unambiguous signal assign-
ment. Resolved multiplet patterns can be considered “fin-
gerprints” of metabolites, permitting accurate assignments
as well as reliable quantification. The quantification of in
vivo 1H NMR spectra is thus expected to be more robust
and accurate, if it is based on a unique spectral pattern of
multiple peaks and if the resonances do not collapse into
a singlet. Improved resolution at 7 T was therefore most
significant for metabolites with J-coupled spin systems,
such as glutamine and glutamate (Fig. 5). The resolution
improved because the overall signal widths of the overlap-
ping multiplets were mainly determined by the homo-
nuclear J-coupling constants, which are independent of B0.
Increased separation of signals corresponding to the H-4
protons of Glu (2.35 ppm) and Gln (2.45 ppm) is a prereq-
uisite for a reliable quantification of those metabolites in
the brain, as illustrated by the simulations in Fig.
5. Precise in vivo quantification of Glu and Gln in the brain
is important, in view of recent studies based on measure-
ments of Glu/Gln cycling between neurons and glia (35,36)
and on the diagnostic and prognostic value of cerebral Gln
signals in metabolic and neurodegenerative disorders (37).
The improved spectral resolution at 7 T is demonstrated
in Fig. 2 (top trace). In addition to strong resonances of
myo-Ins, Glu, Gln, Cho, and total Cr, signals of scyllo-Ins
and Tau are clearly discernible due to good S/N ratio.
Taurine concentration was estimated at 1.5 mmol/g, which
is in good agreement with published data (38). As a result
of highly efficient water suppression, FASTMAP shim-
ming and excellent localization performance, detection of
metabolite signals close to the water resonance, such as
phosphorylethanolamine, was possible (Fig. 2), similar to
rat brain spectra measured at 9.4 T (23). The methylene
resonances of creatine and phosphocreatine have slightly
different chemical shifts, 3.91 ppm and 3.93 ppm, respec-
tively. In the spectra measured at 7 T, the signal at
3.92 ppm was clearly broader than the methyl resonance of
Cr at 3.03 ppm, indicating the potential to quantify both
metabolites separately, as described in rat brain at 9.4 T
(23). The methyl resonance of NAAG was clearly resolved
in a spectrum from parietal white matter (Fig. 3). In a
well-shimmed spectrum measured at 2 T, the NAAG res-
onance was observed only as a downfield shoulder of a
strong NAA peak (5). Increased separation of signals at 7 T
should allow more reliable discrimination between NAA
and aspartate resonances in a region between 2.4–2.9 ppm
and should permit the direct detection of low concentra-
tion metabolites such as GABA or GSH without editing.
In summary, we conclude that in vivo 1H NMR spectros-
copy of the human brain at 7 T leads to increased sensi-
tivity and spectral resolution, which allows unambiguous
signal assignment and quantification with increased reli-
ability.
1H NMR Spectroscopy of the Human Brain 455
REFERENCES
1. Wider G, Wu¨thrich K. NMR spectroscopy of large molecules and mul-
timolecular assemblies in solution. Curr Opin Struct Biol 1999;9:594–
601.
2. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Ha¨nicke W, Sauter R.
Localized proton NMR spectroscopy in different regions of the human
brain in vivo. Relaxation times and concentrations of cerebral metabo-
lites. Magn Reson Med 1989;11:47–63.
3. Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabo-
lites in the human brain. II. Metabolite concentrations. J Magn Reson,
Ser B 1993;102:9–19.
4. Michaelis T, Merboldt KD, Bruhn H, Ha¨nike W, Frahm J. Absolute
concentrations of metabolites in the adult human brain in vivo: quan-
tification of localized proton MR spectra. Radiology 1993;187:219–227.
5. Pouwels PJW, Frahm J. Regional metabolite concentrations in human
brain as determined by quantitative localized proton MRS. Magn Reson
Med 1998;39:53–60.
6. Barfuss H, Fischer H, Hentschel D, Ladebeck R, Oppelt A, Wittig R,
Duerr W, Oppelt R. In vivo magnetic resonance imaging and spectros-
copy of humans with a 4 T whole-body magnet. NMR Biomed 1990;3:
31–45.
7. Langkowski JH, Wieland J, Bomsdorf H, Leibfritz D, Westphal M, Of-
fermann W, Maas R. Pre-operative localized in vivo proton spectros-
copy in cerebral tumors at 4.0 Tesla—first results. Magn Reson Imaging
1989;7:547–555.
8. Gruetter R. Automatic, localized in vivo adjustment of all first- and
second-order shim coils. Magn Reson Med 1993;29:804–811.
9. Gruetter R, Weisdorf SA, Rajanayagan V, Terpstra M, Merkle H, Truwit
CL, Garwood M, Nyberg SL, Ugˇurbil K. Resolution improvements in in
vivo 1H NMR spectra with increased magnetic field strength. J Magn
Reson 1998;135:260–264.
10. Gruetter R, Garwood M, Ugˇurbil K, Seaquist ER. Observation of re-
solved glucose signals in 1H NMR spectra of the human brain at 4 Tesla.
Magn Reson Med 1996;36:1–6.
11. Bartha R, Drost DJ, Menon RS, Williamson PC. Comparison of the
quantification precision of human short echo time 1H spectroscopy at
1.5 and 4.0 Tesla. Magn Reson Med 2000;44:185–192.
12. Posse S, Cuenod CA, Risinger R, Le Bihan D, Balaban RS. Anomalous
transverse relaxation in 1H spectroscopy in human brain at 4 T. Magn
Reson Med 1995;33:246–252.
13. Hetherington HP, Mason GF, Pan JW, Ponder SL, Vaughan JT, Tweig
DB, Pohost GM. Evaluation of cerebral gray and white matter metabo-
lite differences by spectroscopic imaging at 4.1 T. Magn Reson Med
1994;32:565–571.
14. Hetherington HP, Pan JW, Mason GF, Adams D, Vaughn MJ, Twieg DB,
Pohost GM. Quantitative 1H spectroscopic imaging of human brain at
4.1 T using image segmentation. Magn Reson Med 1996;36:21–29.
15. Pan JW, Twieg DB, Hetherington HP. Quantitative spectroscopic imag-
ing of the human brain. Magn Reson Med 1998;40:363–369.
16. Pan JW, Mason GF, Pohost GM, Hetherington HP. Spectroscopic imag-
ing of human brain glutamate by water-suppressed J-refocused coher-
ence transfer at 4.1 T. Magn Reson Med 1996;36:7–12.
17. Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R. Simultaneous
in vivo spectral editing and water suppression. NMR Biomed 1998;11:
266–272.
18. Middleton DA, Hockings PD, Glen S, Reid DG, Rose SE, Crozier S,
Roffman W, Rothaul AL, Hunter AJ, Doddrell DM. Image directed
proton spectroscopy of gerbil brain at 7 Tesla. NMR Biomed 1995;8:
118–126.
19. Penrice J, Lorek A, Cady EB, Amess PN, Wylezinska M, Cooper CE,
D’Souza P, Brown GC, Kirkbride V, Edwards AD, Wyatt JS, Reynolds
EO. Proton magnetic resonance spectroscopy of the brain during acute
hypoxia-ischemia and delayed cerebral energy failure in the newborn
piglet. Pediatr Res 1997;41:795–802.
20. Fernandez EJ, Maudsley AA, Higuchi T, Weiner MW. 1H spectroscopic
imaging of rat brain at 7 Tesla. Magn Reson Med 1992;25:107–119.
21. Fernandez EJ, Maudsley AA, Higuchi T, Weiner MW. Three-dimen-
sional 1H spectroscopic imaging of cerebral metabolites in the rat using
surface coils. Magn Reson Imag 1992;10:965–974.
22. von Kienlin M, Ziegler A, Le Fur Y, Rubin C, Decorps M, Remy C.
2D-spatial/2D-spectral spectroscopic imaging of intracerebral gliomas
in rat brain. Magn Reson Med 2000;43:211–219.
23. Pfeuffer J, Tka´cˇ I, Provencher SW, Gruetter R. Toward an in vivo
neurochemical profile: Quantification of 18 metabolites in short-echo-
time 1H NMR spectra of the rat brain. J Magn Reson 1999;141:104–120.
24. Tka´cˇ I, Starcˇuk Z, Choi I-Y, Gruetter R. In vivo 1H NMR spectroscopy of
rat brain at 1 ms echo time. Magn Reson Med 1999;41:649–656.
25. Provencher SW. Estimation of metabolite concentrations from local-
ized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–679.
26. Adriany G, Yacoub E, Tka´cˇ I, Andersen P, Merkle H, Vaughan JT,
Ugˇurbil K. Shielded surface coils and halfvolume cavity resonators for
imaging and spectroscopy applications at 7 Tesla. In: Proc 8th Annual
Meeting ISMRM, Denver, 2000. p 563.
27. Merkle H, Driesel W, Andersen P, Adriany G, Ugˇurbil K, Garwood M.
Circularly polarized RF helmet coil for brain studies at 7 Tesla. In: Proc
8th Annual Meeting ISMRM, Denver, 2000. p 565.
28. Gruetter R, Tka´cˇ I. Field mapping without reference scan using asym-
metric echo-planar techniques. Magn Reson Med 2000;43:319–323.
29. Seaquist ER, Gruetter R. Identification of a high concentration of scyllo-
inositol in the brain of a healthy human subject using 1H and 13C NMR.
Magn Reson Med 1998;39:313–316.
30. Govindaraju V, Young K, Maudsley AA, Proton NMR chemical shifts
and coupling constants for brain metabolites. NMR Biomed 2000;23:
129–153.
31. Terpstra M, Andersen P, Gruetter R. Localized eddy current compen-
sation using quantitative field mapping. J Magn Reson 1998;131:139–
143.
32. van der Toorn A, Dijkhuizen RM, Tulleken CA, Nicolay K. T1 and T2
relaxation times of the major 1H-containing metabolites in rat brain
after focal ischemia. NMR Biomed 1995;8:245–52.
33. Lenz C, Frietsch T, Futterer C, Rebel A, van Ackern K, Kuschinsky W,
Waschke KF, Local coupling of cerebral blood flow to cerebral glucose
metabolism during inhalational anesthesia in rats: desflurane versus
isoflurane. Anesthesiology 1999;91:1720–1723.
34. Gruetter R, Ugˇurbil K, Seaquist ER. Steady-state cerebral glucose con-
centrations and transport in the human brain. J Neurochem 1998;70:
397–408.
35. Gruetter R, Seaquist E, Kim S-W, Ugˇurbil K. Localized in vivo 13C NMR
of glutamate metabolism. Initial results at 4 Tesla. Dev Neurosci 1998;
20:380–388.
36. Shen J, Petersen KF, Behar KL, Brown P, Nixon TW, Mason GF, Petroff
OA, Shulman GI, Shulman RG, Rothman DL. Determination of the rate
of the glutamate/glutamine cycle in the human brain by in vivo 13C
NMR. Proc Natl Acad Sci USA 1999;96:8235–8240.
37. Jenkins BG, Klivenyi P, Kustermann E, Andreassen OA, Ferrante RJ,
Rosen BR, Beal MF. Nonlinear decrease over time in N-acetyl aspartate
level in the absence of neuronal loss and increases in glutamine and
glucose in transgenic Huntington’s disease mice. J Neurochem 2000;
74:2108–2119.
38. Ellison DW, Beal MF, Martin JB. Amino acid neurotransmitters in
postmortem human brain analyzed by high performance liquid chro-
matography with electrochemical detection. J Neurosci Meth 1987;19:
305–315.
456 Tka´cˇ et al.
